Common antibiotic tested in massive effort to save babies in High-Risk region

NCT ID NCT03909737

Summary

This large study in Mali is testing whether giving a single dose of the antibiotic azithromycin to pregnant women during prenatal care and to infants during vaccination visits can prevent stillbirths and reduce deaths in babies up to one year old. Nearly 100,000 participants will receive either the antibiotic or a placebo during their routine healthcare visits. The goal is to provide clear evidence to help policymakers decide if adding this simple, low-cost treatment to standard care could save lives in areas with very high infant mortality.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STILLBIRTHS AND INFANT MORTALITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Centre pour le Developpement des Vaccins - Mali

    Bamako, Mali

Conditions

Explore the condition pages connected to this study.